11 – 14 October 2019 Nice-Acropolis Convention Center · Nice-Acropolis Convention Center, Nice,...

WWW.TIMM2019.ORG

Second announcement

11 – 14 October 2019

Nice-Acropolis Convention CenterNice, France

9th Trends in Medical Mycology

2

Important dates

1 May Deadline early-bird registration fee1 June Abstract deadlineJuly Abstracts letters of acceptance will be mailed1 August Deadline late breaking abstracts*16 September Deadline regular registration fee

* for information on late breaking abstract requirements see www.timm2019.org

See congress website for the latest information:

www.TIMM2019.orgTrends in Medical Mycology is the bi-annual joined meeting of the Infectious Disease Group of the European Organisation for Research and Treatment of Cancer (EORTC) and European Confederation of Medical Mycology (ECMM)

ECMM Society Office & Organisation

Congress CareP.O. Box 4405201 AK ‘s-HertogenboschThe NetherlandsTel [email protected]

2 3

Introduction

Dear Friends and Colleagues, It is a great honour and pleasure for us to invite you cordially to participate in the 9th Congress on Trends in Medical Mycology (TIMM-9), which will be held in October 11-14, 2019 at Nice-Acropolis Convention Center, Nice, France. TIMM-9 is the 9th in the series of TIMM mycological international meetings organized jointly by the European Confederation of Medical Mycology (ECMM) and the Infectious Diseases Group of the European Organisation for Research and Treatment of Cancer (EORTC-IDG). TIMM has become an important and essential meeting in the field of fungal infections, a forum in which researchers and clinicians from all over the world present the most important advances and research findings in clinical mycology. TIMM-9 will cover all aspects of mycology with special focus on evidence-based and personalized approach to medical mycology, as well as diagnostic-therapeutic integrative efforts in the quest to improve the present knowledge of epidemiology, diagnosis, clinical course and pathophysiological mechanisms of fungal diseases. It would be the place to present recent innovations in medical mycology. The meeting is designed for medical microbiologists, medical mycologists, heamatologists, oncologists, transplant physicians, intensivists, immunologists, and all those with interest in medical mycology. We expect TIMM-9 to be at least as successful as previous TIMM Congresses, which brought together around 1,000 international delegates from all over the world. Therefore, we would like to invite you to TIMM-9 in Nice to enjoy with us excellent science in a stimulating environment. We look forward to greeting you in Nice!

Jean-Pierre GangneuxOlivier LortholaryOliver A. CornelyLivio Pagano

TIMM-9 Executive Committee

4 5

Committees

Executive CommitteeJean-Pierre Gangneux, ECMM, FranceOlivier Lortholary, EORTC, FranceLivio Pagano, EORTC, ItalyOliver A. Cornely, ECMM, Germany

International Scientific CommitteeHamdi Akan, EORTC, TurkeyValentina Arsić Arsenijević, ECMM, SerbiaSharon Chen, ECMM, AustraliaRaoul Herbrecht, EORTC, FranceMartin Hoenigl, ECMM, AustriaNikolai Klimko, ECMM, RuslandKatrien Lagrou, ECMM, BelgiumJohan Maertens, EORTC, BelgiumJacques F. Meis, ECMM, the NetherlandsTony Pagliuca, EORTC, UKZděnek Racil, EORTC, Czech RepublicEster Segal, ECMM, IsraelDon Sheppard, ECMM, CanadaPaul Verweij, EORTC, the NetherlandsThomas Walsh, ECMM, USA

Local Scientific CommitteeJean-Pierre Gangneux, RennesOlivier Lortholary, ParisAlexandre Alanio, ParisJean-Philippe Bouchara, AngersMarie-Elizabeth Bougnoux, ParisStephane Bretagne, ParisChristophe D’Enfert, ParisJean-Paul Latgé, ParisLaurence Millon, Besançon

6

Programme at a glance

FRIDAY 11 OCTOBER 2019

09:00 - 12:00 ECMM council meeting

12:00 - 12:30 Coffee break

12:30 - 12:45 Welcome address

12:45 - 13:45 Plenary session 1 - Tropical

13:45 - 15:15 Parallel Symposia 1-4

S1Water quality (mis-)management – an opportunity for fungal conta-mination

S2 Pneumocystis jirovecii, an airborne transmissible and human derived ascomycete showing strong pulmonary tropism

S3 Mucormycosis

S4 MSG symposium (Trial Design in Clinical Mycology: Innova-tive Approaches)


15:30 - 16:30 Sponsored Diagnostic Symposium

16:45 - 18:15 Sponsored Integrated Symposium 1

18:30 - 19:00 E. Drouhet lecture (ECMM)

19:00 - 20:00 Welcome reception

6 7

SATURDAY 12 OCTOBER 2019

08:00 - 08:45 Meet the expert sessions

M1 Hematology

M2 Peadiatrics

M3 Candida ICU

M4 Diagnostics/Laboratory

M5Tropical

08:50 - 10:00 Plenary session 2 - Highlights on fungal biology


10:30 - 11:30 Plenary session 3 - One World One Guideline ECMM MSG-ERC (EFISG) ISHAM Guidelines initiative

11:30 - 12:30 Poster session 1

12:30 - 14:15 Lunch



S5Lung trans-plantation

S6 Prophylaxis during hematology malginances

S7 Paediatric Mycology (EPMyN)

S8 Immunologic Markers for Diagnosis and Treatment Stratification in Invasive Mold Infection

S9Chronic pulmonary aspergillosis



S10Sensing the host

S11The anti-fun-gal pipeline

S12Environment & fungal outbreaks

S13Fungal respiratory infections in cystic fibrosis (ECMM/ISHAMworking Group Fri-CF)

S14Teaching Medical Mycology: what, how, to whom and when


19:30 - 20:30 Sponsored reception

8

Programme at a glance

SUNDAY 13 OCTOBER 2019


M6 Hematology -hematopicstem cell HST

M7 Molecular diagnostics

M8 Surgery / transplantation

M9 Neonates

M10 Meet Mr. and Mrs. Fungus

08:50 - 09:50 Plenary session 4 - Top 10 papers in Mycology

09:50 - 10:00 ECMM Academy and Excellence Centers: A story of success


10:30 - 11:30 Plenary session 5 - ICU - candida infections / Breaking news from Hematology and ICU


12:30 - 14:15 Lunch



S15 Aspergillis in ICU

S16 Derma

S17 HIV associated crypto meningitis

S18 Antifungal stewardship in the era of resistance

S19 Pneumocystis



S20 Candida auris

S21Immuno-therapy for opportunistic fungal infections

S22NGS and mycobiota

S23The funny life of C. albicans in the oral tract

S24Fungalneglectedtropicaldiseases

18:00 - 19:00 Ben De Pauw Lectures (EORTC)

19:30 Congress dinner

8 9

MONDAY 14 OCTOBER 2019


M11 HIV

M12 Environment

M13 Diagnostics / imaging

M14 Resistance

M15 Registries

08:50 - 10:00 Plenary session 6 - Management of IFD in paediatrics (EPMyN)


10:30 - 11:30 Plenary session 7 - Superficial & Derma

11:30 - 12:30 Plenary session 8 - New (antineoplastic) drugs, new risks

12:30 Closing TIMM-9

10

TIMM-9, Scientific Programme

Friday 11 October 2019

09:00 - 12:00 ECMM council meeting


12:30 - 12:45 Welcome address

12:45 - 13:45 Plenary session 1 - Tropical

PS1.1 Histoplasmosis PS1.2 Emergomycosis

13:45 - 15:15 Parallel Symposia 1-4 Water quality (mis-)management –

an opportunity for fungal contamination S01.1 Fungal contaminants in drinking water regulation?

A tale of ecology, exposure, purification and clinical relevance

S01.2 Hospital environment: water supply and containment of

aerosolised fungal particles. How far must we go in times of antimicrobial resistance?

S01.3 Potential transmission pathways of clinically relevant fungi in indoor swimming pool facilities

Selected abstracts Pneumocystis jirovecii, an airborne transmissible and

human derived ascomycete showing strong pulmonary tropism

S02.1 Pneumocystis jirovecii: an obligate parasite of human lungs with unique camouflage and sex strategies

S02.2 High-throughput methodologies in molecular epidemiology of Pneumocystis jirovecii

10 11

S02.3 Airborne acquisition and transmission of Pneumocystis jirovecii: an update

S02.4 Pneumocystis in non-traditional risk groups

Mucormycosis

S03.1 Hospital related mucormycosis

S03.2 Presentation from Ramstein airbase

S03.3 The new treatment of mucormycosis

S03.4 Clinical features associated to fungal speci

S03.5 Molecular diagnosis

S03.6 Management of Mucormycosis in Low and Middle Income Countries

MSG symposium (Trial Design in Clinical Mycology: Innovative Approaches)

S04.1 Candidiasis

S04.2 Endemic Mycoses

S04.3 Cryptococcosis

S04.4 Aspergillosis and other molds


15:30 - 16:30 Sponsored Diagnostic Symposium


18:30 - 19:00 E. Drouhet lecture (ECMM)

19:00 - 20:00 Welcome reception

12

Saturday 12 october 2019 08:00 - 08:45 Meet the expert sessions 1-5

M01 Hematology M02 Peadiatrics

M03 Candida ICU

M04 Diagnostics/Laboratory

M05 Tropical

08:50 - 10:00 Plenary session 2 - Highlights on fungal biology

PS 2.1 Candida

PS 2.2 Aspergillus

Selected abstracts


10:30 - 11:30 Plenary session 3 - One World One Guideline ECMM MSG-ERC (EFISG) ISHAM Guidelines initiative

PS3.1 Mucormycosis

PS3.2 Endemic

PS3.3 Rare moulds

PS3.4 Rare yeasts


12:30 - 14:15 Lunch break


12 13


Lung transplantation

S05.1 Pre-transplant assesment

S05.2 Prophylaxis

S05.2 Current guidelines

Selected abstracts

Prophylaxis during hematology malginances

S06.1 AML - in the era of FLT3 inhibitors

S06.2 ALL - there is a role for prophylaxis

S06.3 Personalised medicine / approach by genetic risk factors S06.4 Baseline CT upon diagnosis of Acute leukemia Paediatric Mycology (EPMyN)

S07.1 Fluconazole and micafungin dosing in neonates

S07.2 Antifungal susceptibility of paediatric candidemia

S07.3 Primary immunodeficiencies characterized by fungal infections

Selected abstracts

Immunologic Markers for Diagnosis and Treatment Stratification in Invasive Mold Infection

S08.1 Anti-Mold Immune Response: the impact of the host, the

pathogen and translational implications

S08.2 Immunologic Markers for Diagnosis of invasive Aspergillosis and other invasive Mold infections

S08.3 Immunologic Markers for Treatment Stratification in Invasive Mold Infection

14

S08.4 Multicenter Study: Immunologic Markers for Treatment Monitoring and Diagnosis in Invasive Mold Infection

Chronic pulmonary aspergillosis

S09.1 The global burden of chronic pulmonary aspergillosis

S09.2 Diagnosis of CPA. Where do we stand?

S09.3 Current treatment options for CPA

S09.4 Future directions



Sensing the host S10.1 Phosphate acquisition and virulence in human fungal

pathogens S10.2 Hybrid histidine kinases: major sensing proteins in

pathogenic fungi

S10.3 CO2 sensing in fungi: at the heart of metabolic signaling

Selected abstracts

S11 The anti-fungal pipeline

Environment & fungal outbreaks

S12.1 Frogs

S12.2 Cryptococcus - gattii

S12.3 Natural disasters

S12.4 Genomic sequencing

14 15

Fungal respiratory infections in cystic fibrosis (the ECMM/ISHAM working Group Fri-CF)

S13.1 Rasamsonia species and other emerging fungi in CF

S13.2 Immunodiagnosis of Scedosporium/Lomentospora infection - lessons from immunoproteomic studies

S13.3 Bacterial / Fungal interactions in the CF mucus Selected abstracts

Teaching Medical Mycology: what, how, to whom and when

S14.1 Mycology teaching in Medical School - How much, what to choose, at what level

S14.2 Mycology teaching in Medical School - Is student demography important to what should be taught

S14.3 Specific courses outside European Continent - The Indian Example

S14.4 Teaching Clinical Laboratory Mycology - How and who is the audience

S14.5 The African example


19:30 - 20:30 Sponsored reception

16

Sunday 13 october 2019

08:00 - 08:45 Meet the expert sessions 6-10

M6 Hematology - hematopic stem cell HST

M7 Molecular diagnostics

M8 Surgery / transplantation

M9 Neonates

M10 Meet Mr. and Mrs. Fungus

08:50 - 09:50 Plenary session 4 - Top 10 papers in Mycology

PS4.1 Clinical mycology PS4.2 Microbiology

09:50 - 10:00 ECMM Academy and Excellence Centers: A story of success


10:30 - 11:30 Plenary session 5 - ICU - candida infections / Breaking news from Hematology and ICU

PS5.1 Peritonitis

PS5.2 Are the new management strategies useful?

PS5.3 CNS infections

PS5.4 CMV and aspergillosis in HSCT patients


12:30 - 14:15 Lunch


16 17


Aspergillis in ICU

S15.1 Influenza

S15.2 Invasive aspergillosis in patients with underlying liver cirrhosis

Selected abstracts

Derma

S16.1 Malassezia infections. Too insignificant to mention?

S16.2 Is resistance a problem for dermatophytosis?

S16.3 Phaeohyphomycosis

S16.4 Blastomycosis

Selected abstracts

HIV associated crypto meningitis

S17.1 Screening in low-resource area

S17.2 Current therapeutic strategies

S17.3 Towards having antifungal drugs in low-resource area

S17.4 Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis

S18 Antifungal stewardship in the era of resistance

18

Pneumocystis

S19.1 Diagnosis

S19.2 Pneumocystosis and HIV

S19.3 Pneuomcystosis in non-HIV patients

S19.4 Pneumocystosis in neonates



Candida auris

S20.1 In resource limited countries

S20.2 In the US

S20.3 Outbreak control

Selected abstracts

Immunotherapy for opportunistic fungal infections

S21.1 CAR-T cells, NK cells

S21.2 WBC transfusions

S21.3 Cytokines

Selected abstracts

NGS and mycobiota

S22.1 Respiratory Mycobiome in Chronic Airway Inflammatory Diseases and Emerging Relationships with the Host

Immune Response

S22.2 Respiratory Mycobiome – A Clinical Perspective

S22.3 Characterization of indoor dust microbiota in homes of asthma and non asthma patients

18 19

S22.4 Understanding the role of the gut mycobiome in health and diseas

Selected abstracts The funny life of C. albicans in the oral tract

S23.1 Within-Host Genomic Diversity of Candida albicans in Healthy Carriers

S23.2 Rapid phenotypic and genotypic diversification after exposure to the oral host niche in Candida albicans

S23.3 Modulation of the Fungal-Host Interaction by the Intra-Species Diversity of C. albicans

S23.4 Intestial Th17 drives airway inflammation in ABPA

Fungal neglected tropical disease

S24.1 Mycetome

S24.2 Chromoblastomycosis

S24.3 Sporotrichosis

Selected abstracts

18:00 - 19:00 Ben De Pauw Lectures (EORTC)

19:30 Congress dinner

20

Monday 14 october 2019 08:00 - 08:45 Meet the expert sessions 11-15

M11 HIV M12 Environment

M13 Diagnostics / imaging

M14 Resistance

M15 Registries

08:50 - 10:00 Plenary session 6 - Management of IFD in paediatrics (EPMyN)

PS6.1 Biomarker based diagnostic work-up of IFD in immunocompromised paediatric patients

PS6.2 Pre-emptive versus empiric antifungal therapy in in children with cancer

Selected abstracts


10:30 - 11:30 Plenary session 7 - Superficial & Derma

PS7.1 When the skin is the porter of invasive infections

PS7.2 When the skin talks for systemic infections

11:30 - 12:30 Plenary session 8 - New (antineoplastic) drugs, new risks

PS8.1 In hematology

PS8.2 In oncology

12:30 Closing TIMM-9 & presentation TIMM-10

20 21

Registration fees

Early Bird Regular Late (1 May ‘19) (until 16 Sept ‘19) (from 16 Sept ‘19 and on-site)ECMM/EORTC- members EUR 495 EUR 795 EUR 975Non-members EUR 775 EUR 1095 EUR 1295Physicians/scientists in training* EUR 395 EUR 595 EUR 795Day-registration EUR 400 EUR 400 EUR 400Emerging Economy Rate** EUR 195 EUR 300 EUR 395

Conditions * Physicians/scientists in training have to provide a written certification by the head

of department.** Emerging Economy Rate is applied to individuals (no group registrations) from

low-income and lower-middle-income economies according to the World Bank listing available at the website of the World Bank.

What is included in the registration fee?The registration fee for delegates includes: Admission to the meeting, welcome reception, certificate of attendance, 2 lunches and all coffee breaks.

Congress dinner SundayDinner tickets are available at the price of EUR 100. Please make your reservation when you register online.

Registration & paymentRegistration is possible via the congress website. Payment can be done online by: creditard (Mastercard / Visa) or SEPA direct debit.

Group registrationsFor group registrations; please contact the congress secretariat via: [email protected], before starting your group registration. Group registration is available for groups of 5 participants or more.

CancellationCancellations and refund requests must be submitted in writing to the congress secretariat. Cancellations made before 1 July 2019 will be refunded less 30% to cover administration costs. After this date no refunds will be given. All refunds will be made after the congress.

22

General information

LocationTIMM-9 will be held in the Nice-Acropolis Convention Center, Nice, France. The Nice Côte d’Azur Airport is France’s second-largest international airport. It is located 15 minutes from the Acropolis (7 km from the city centre). Several hotels are situated on walking distance of the congress center.Nice has an excellent public transport system with stops in front of the congress center. For more info please check: www.timm2019.org.

TimingThe congress will start on Friday 11 October 2019 with registration, symposia, keynote lectures, sponsored symposia, opening ceremony and welcome reception. The congress will end on Monday 14 October 2019 at noon.

Abstract deadlineThe deadline for abstract submission is 1st of June 2019. For more information please see the section abstracts on the congress website.

Congress languageThe official language of the congress will be English. No simultaneous translation will be available.

Exhibition & sponsored symposiaA targeted group of biotechnical and pharmaceutical companies will be invited to organise a sponsored integrated symposium and/or exhibit their products and services.

InsuranceIn registering for the 9th Trends in Medical Mycology delegates agree that neither the organisation nor the congress agency Congress Care is responsible for individual medical, travel or personal insurance. Delegates are requested to arrange their own travel and health insurance. The organizers cannot assume liability for changes in the program due to external circumstances.

22 23

Sponsors and exhibitors

Major sponsors (per April 2019)

ECMM Society Office & Congress OrganisationCongress CareP.O. Box 4405201 AK ‘s-HertogenboschThe NetherlandsTel [email protected]

WWW.TIMM2019.ORG

11 – 14 October 2019 Nice-Acropolis Convention Center · Nice-Acropolis Convention Center, Nice,...

Documents

Transcript of 11 – 14 October 2019 Nice-Acropolis Convention Center · Nice-Acropolis Convention Center, Nice,...